November 2024
Diabetes Medicines
Type 2 diabetes: reducing the impact of cardiovascular and renal disease
This topic covers:
- Early and continuing lifestyle interventions are the foundation of diabetes management.
- Metformin is the first line medicine in type 2 diabetes unless contraindicated or not tolerated.
- Consider early use of SGLT2 inhibitors for people with comorbidities.
- Be aware of recent changes in the PBS restrictions impacting access to the use of SGLT2 inhibitors and GLP-1As medicines.
Be aware of recent changes in the PBS restrictions impacting access to the use of SGLT2 inhibitors and GLP-1A medicines
Sign up for email updates from MAIA
We send out occasional updates - no more than once a month.
Medicines stewardship resources for service providers
This topic covers:
- Early and continuing lifestyle interventions are the foundation of diabetes management.
- Metformin is the first line medicine in type 2 diabetes unless contraindicated or not tolerated.
- Consider early use of SGLT2 inhibitors for people with comorbidities.
- Be aware of recent changes in the PBS restrictions impacting access to the use of SGLT2 inhibitors and GLP-1As medicines.